CAB LA PrEP Cohort: Prospective Cohort Study to Assess Effectiveness and Safety of, and Adherence and Resistance to Cabotegravir for Pre-Exposure Prophylaxis in the United States (217671)

First published 22/05/2024

Last updated 08/10/2025

EU PAS number:

EUPAS1000000163

Study

Ongoing

Documents

Study protocol

Initial protocol

CAB_LA_for_PrEP_Prospective_Cohort_Study_in_the_US_Final_Protocol_Anonymised.pdf

English (650.79 KB - PDF) View document

Study results

Study report

Other information

Secondary tabs